Get the Stockscreener App
1.72
1.71%
-0.03
After Hours:
1.72
Essa Pharma Inc stock is traded at $1.72, with a volume of 59,814.
It is down -1.71% in the last 24 hours and down -1.15% over the past month.
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.
See More
Previous Close:
$1.75
Open:
$1.73
24h Volume:
59,814
Relative Volume:
0.18
Market Cap:
$76.35M
Revenue:
-
Net Income/Loss:
$-28.54M
P/E Ratio:
-2.6875
EPS:
-0.64
Net Cash Flow:
$-22.72M
1W Performance:
-0.58%
1M Performance:
-1.15%
6M Performance:
-68.15%
1Y Performance:
-79.02%
1-Day Range:
$1.72
$1.76
1-Week Range:
$1.71
$1.765
52-Week Range:
$1.40
$9.92
Essa Pharma Inc Stock (EPIX) Company Profile
Name
Essa Pharma Inc
Sector
Industry
Phone
(778) 331-0962
Address
SUITE 720, VANCOUVER, BC
Compare EPIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
1.72 | 76.35M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-04-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-04-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jun-26-23 | Resumed | Oppenheimer | Outperform |
| Mar-04-21 | Initiated | Piper Sandler | Overweight |
| Jan-11-21 | Reiterated | H.C. Wainwright | Buy |
| Nov-02-20 | Initiated | Jefferies | Buy |
| Oct-25-19 | Initiated | Oppenheimer | Outperform |
View All
Essa Pharma Inc Stock (EPIX) Latest News
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit - PR Newswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Class Action Filed Against ESSA Pharma Inc. (EPIX)March 25, 2025 Deadline to JoinContact Levi & Korsinsky - Stockhouse Publishing
2025-02-21 | Shareholders of ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - Kilgore News Herald
Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - The Malaysian Reserve
Investors who lost money on ESSA Pharma Inc.(EPIX) should contact The Gross Law Firm about pending Class ActionEPIX - The Malaysian Reserve
EPIX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. LawsuitEPIX - ACCESS Newswire
2025-02-19 | Investors who Lost Money on ESSA Pharma Inc. (EPIX) Should Contact Levi & Korsinsky about Pending Class ActionEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ... - The Bakersfield Californian
Investors in ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX - Stockhouse Publishing
Investors who lost money on ESSA Pharma Inc.(EPIX) should - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before ... - The Bakersfield Californian
ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
2025-02-17 | Shareholders that Lost Money on ESSA Pharma Inc. (EPIX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More | NDAQ:EPIX | Press Release - Stockhouse Publishing
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
2025-02-16 | ESSA Pharma Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
2025-02-16 | ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
2025-02-16 | INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma | NDAQ:EPIX | Press Release - Stockhouse Publishing
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Markets Insider
ESSA Pharma (NASDAQ:EPIX) Announces Earnings Results - MarketBeat
EPIX STOCK NEWS: EPIX Shareholders with Large Losses Should - GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. - GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before - The Bakersfield Californian
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important - EIN News
2025-02-14 | ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire
Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – EPIX - GlobeNewswire
Lawsuit filed for Investors who lost money with shares of ESSA Pharma Inc. (NASDAQ: EPIX) - openPR
2025-02-13 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. LawsuitEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - PR Newswire
ESSA Pharma Inc. Explores Strategic Options Amid Losses - TipRanks
2025-02-12 | Shareholders that Lost Money on ESSA Pharma Inc. (EPIX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More | NDAQ:EPIX | Press Release - Stockhouse Publishing
ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
2025-02-11 | Shareholders that lost money on ESSA Pharma Inc.(EPIX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More | NDAQ:EPIX | Press Release - Stockhouse Publishing
2025-02-11 | Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before - The Bakersfield Californian
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain OfficersEPIX - PR Newswire
ESSA Pharma: Fiscal Q1 Earnings Snapshot - San Antonio Express-News
ESSA Pharma Reports Q1 Loss, Explores Strategic Options - TipRanks
SEC Form 10-Q filed by ESSA Pharma Inc. - Quantisnow
ESSA Pharma Inc. (EPIX) reports earnings - Quartz
ESSA Pharma Inc. SEC 10-Q Report - TradingView
ESSA Pharma's Strategic Pivot: $120M War Chest Powers Hunt for Next Big Move - StockTitan
ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationEPIX - PR Newswire
ESSA Pharma (EPIX) Expected to Announce Earnings on Tuesday - Defense World
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
Essa Pharma Inc Stock (EPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Essa Pharma Inc Stock (EPIX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Virsik Peter | Chief Operating Officer |
Oct 07 '24 |
Sale |
6.03 |
694 |
4,185 |
7,776 |
| Virsik Peter | Chief Operating Officer |
Sep 09 '24 |
Sale |
6.00 |
694 |
4,164 |
8,470 |
| Virsik Peter | Chief Operating Officer |
Sep 03 '24 |
Sale |
6.03 |
2,082 |
12,554 |
9,164 |
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):